Category Archives: Lung Cancer

November is Lung Cancer Awareness Month

According to Globocan 2018, in both sexes combined, lung cancer is the most commonly diagnosed cancer (11.6% of the total cases) and the leading cause of cancer death (18.4% of the total cancer deaths). In November all stakeholders mark the Lung Cancer Awareness Month and Lung Cancer Europe will continue to raise awareness about inequities regarding the access to lung […]

Read More

New GLOBOCAN statistics placed lung cancer as the most frequent cancer and the leading cause of cancer death among males

According to tthe new statistics, in both sexes combined, lung cancer is the most commonly diagnosed cancer (11.6 % of the total cases) and the leading cause of cancer death (18.4 % of the total cancer deaths), closely followed by female breast cancer (11.6 %), prostate cancer (7.1 %), and colorectal cancer (6.1 %) for incidence and colorectal cancer (9.2 […]

Read More

#WCLC2018 conclusions – Strategies to Maximize the Clinical Benefit of EGFR TKIs in Advanced NSCLC

During the congress, one of the topics covered focused on the importance of EGFR TKIs in Advanced NSCLC. Apply expert recommendations for frontline therapy for advanced EGFR-mutated NSCLC focusing on safety, efficacy, and the individualization of therapy based on tumor-specific and patient-specific factors Compare the efficacy and safety of first-generation EGFR TKIs with later-generation EGFR TKIs Examine current recommendations for molecular […]

Read More